Cargando…
Minimum sample size estimates for trials in inflammatory bowel disease: A systematic review of a support resource
BACKGROUND: Of 25% of randomised controlled trials (RCTs) on interventions for inflammatory bowel disease (IBD) have no power calculation. AIM: To systematically review RCTs reporting interventions for the management of IBD and to produce data for minimum sample sizes that would achieve appropriate...
Autores principales: | Gordon, Morris, Lakunina, Svetlana, Sinopoulou, Vasiliki, Akobeng, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613748/ https://www.ncbi.nlm.nih.gov/pubmed/34887650 http://dx.doi.org/10.3748/wjg.v27.i43.7572 |
Ejemplares similares
-
Sample‐size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: A systematic review
por: Iheozor‐Ejiofor, Zipporah, et al.
Publicado: (2021) -
Remote care through telehealth for people with inflammatory bowel disease
por: Gordon, Morris, et al.
Publicado: (2023) -
Patient education interventions for the management of inflammatory bowel disease
por: Gordon, Morris, et al.
Publicado: (2023) -
Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023) -
Racecadotril for acute diarrhoea in children: systematic review and meta-analyses
por: Gordon, Morris, et al.
Publicado: (2016)